Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sen. Byrd's Seat Could Be Filled By More Rx-Focused Successor

This article was originally published in The Pink Sheet Daily

Executive Summary

West Virginia Gov. Manchin addressed the PhRMA annual meeting in March.

You may also be interested in...

Manchin To HELP, For Now

The eventual structure of any user fees that the generic industry may pay could be shaped to some degree by the makeup of the Senate's Health, Education, Labor and Pensions Committee, which would have responsibility for any user fee bills. So the presence of newly-elected Sen. Joe Manchin, D-W.Va., who has joined the panel at least for the rest of the year, is interesting.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts